• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

停用甲氨蝶呤后中枢神经系统甲氨蝶呤相关淋巴增殖性疾病复发:一例报告

Recurrence of Central Nervous System Methotrexate-related Lymphoproliferative Disorder after Methotrexate Discontinuation: A Case Report.

作者信息

Okada Yoshihiro, Tomita Yusuke, Nishimori Hisakazu, Ueno Hiroki, Matsuura Kanji, Makino Keigo, Kidani Naoya, Muraoka Kenichiro, Hirotsune Nobuyuki, Nishino Shigeki

机构信息

Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Hiroshima, Japan.

Department of Hematology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Hiroshima, Japan.

出版信息

NMC Case Rep J. 2025 Jun 11;12:255-260. doi: 10.2176/jns-nmc.2024-0296. eCollection 2025.

DOI:10.2176/jns-nmc.2024-0296
PMID:40599308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209498/
Abstract

Methotrexate-related lymphoproliferative disorder is a rare but serious complication of methotrexate treatment. Recurrent methotrexate-related lymphoproliferative disorder in the central nervous system is uncommon. An 86-year-old woman, who had been on methotrexate for 3 years to treat rheumatoid arthritis, was admitted with left hemiplegia and sensory disturbance. Brain magnetic resonance imaging revealed a right basal ganglia lesion that was hyperintense on diffusion-weighted imaging and showed patchy enhancement. Methotrexate-related lymphoproliferative disorder was suspected, and methotrexate was discontinued, which led to improvement in her symptoms and partial remission. Twenty-eight months after methotrexate cessation, the patient presented with reduced activity and left hemiparesis. Brain magnetic resonance imaging showed homogeneously enhancing lesions in the right frontal lobe, basal ganglia, and brainstem. A craniotomy for biopsy of the right frontal lobe lesion confirmed the diagnosis of methotrexate-related lymphoproliferative disorder. Whole-brain radiation (40 Gy in 20 fractions) was administered without chemotherapy due to her advanced age and poor performance status. Her symptoms improved, and she was transferred to a rehabilitation hospital. Methotrexate-related lymphoproliferative disorder of the central nervous system can recur spontaneously, even without resumption of methotrexate, making long-term follow-up necessary after methotrexate cessation.

摘要

甲氨蝶呤相关的淋巴增殖性疾病是甲氨蝶呤治疗罕见但严重的并发症。中枢神经系统复发性甲氨蝶呤相关的淋巴增殖性疾病并不常见。一名86岁女性,因类风湿关节炎服用甲氨蝶呤3年,因左侧偏瘫和感觉障碍入院。脑磁共振成像显示右侧基底节区病变,在扩散加权成像上呈高信号,并显示斑片状强化。怀疑为甲氨蝶呤相关的淋巴增殖性疾病,停用甲氨蝶呤后,患者症状改善并部分缓解。停用甲氨蝶呤28个月后,患者出现活动减少和左侧偏瘫。脑磁共振成像显示右侧额叶、基底节区和脑干有均匀强化的病变。对右侧额叶病变进行开颅活检确诊为甲氨蝶呤相关的淋巴增殖性疾病。由于患者年龄较大且身体状况较差,未进行化疗,仅给予全脑放疗(20次分割,共4 Gy)。她的症状有所改善,随后被转至康复医院。中枢神经系统甲氨蝶呤相关的淋巴增殖性疾病即使在未重新使用甲氨蝶呤的情况下也可能自发复发,因此在停用甲氨蝶呤后需要进行长期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/dac6335ceb7c/2188-4226-12-0255-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/faea375f60e8/2188-4226-12-0255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/b3416dcb6fee/2188-4226-12-0255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/13c3b4a14dc9/2188-4226-12-0255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/dac6335ceb7c/2188-4226-12-0255-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/faea375f60e8/2188-4226-12-0255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/b3416dcb6fee/2188-4226-12-0255-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/13c3b4a14dc9/2188-4226-12-0255-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc7/12209498/dac6335ceb7c/2188-4226-12-0255-g004.jpg

相似文献

1
Recurrence of Central Nervous System Methotrexate-related Lymphoproliferative Disorder after Methotrexate Discontinuation: A Case Report.停用甲氨蝶呤后中枢神经系统甲氨蝶呤相关淋巴增殖性疾病复发:一例报告
NMC Case Rep J. 2025 Jun 11;12:255-260. doi: 10.2176/jns-nmc.2024-0296. eCollection 2025.
2
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.生物制剂或托法替布用于初治类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657.
3
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
4
Methotrexate for induction of remission in refractory Crohn's disease.甲氨蝶呤用于诱导难治性克罗恩病缓解
Cochrane Database Syst Rev. 2012 Dec 12;12:CD003459. doi: 10.1002/14651858.CD003459.pub3.
5
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).生物制剂或托法替布单药治疗传统抗风湿药物(DMARD)治疗失败的类风湿关节炎患者:一项Cochrane系统评价和网状Meta分析(NMA)
Cochrane Database Syst Rev. 2016 Nov 17;11(11):CD012437. doi: 10.1002/14651858.CD012437.
6
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.成人伴或不伴有广场恐惧症的惊恐障碍的心理治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 Apr 13;4(4):CD011004. doi: 10.1002/14651858.CD011004.pub2.
7
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.生物制剂或托法替布用于对甲氨蝶呤或其他传统改善病情抗风湿药物反应不完全的类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2016 May 13;2016(5):CD012183. doi: 10.1002/14651858.CD012183.
8
Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.中枢神经系统淋巴细胞增生性疾病继发于甲氨蝶呤:系统文献回顾与病例举例。
World Neurosurg. 2023 Nov;179:118-126. doi: 10.1016/j.wneu.2023.08.018. Epub 2023 Aug 12.
9
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.生物制剂或托法替布用于生物制剂治疗类风湿关节炎失败的患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD012591. doi: 10.1002/14651858.CD012591.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Imaging Features of Immunodeficiency-Associated Primary CNS Lymphoma: A Review.免疫缺陷相关原发性中枢神经系统淋巴瘤的影像学特征:综述
Can Assoc Radiol J. 2025 Feb;76(1):113-121. doi: 10.1177/08465371241259951. Epub 2024 Jun 20.
2
Methotrexate‑related other iatrogenic immunodeficiency‑associated lymphoproliferative disorder in the CNS and medication‑related osteonecrosis of the jaw occurring simultaneously: A case report.甲氨蝶呤相关的中枢神经系统其他医源性免疫缺陷相关淋巴增殖性疾病与颌骨药物相关性骨坏死同时发生:一例报告
Exp Ther Med. 2023 Nov 28;27(1):41. doi: 10.3892/etm.2023.12329. eCollection 2024 Jan.
3
Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.
中枢神经系统淋巴细胞增生性疾病继发于甲氨蝶呤:系统文献回顾与病例举例。
World Neurosurg. 2023 Nov;179:118-126. doi: 10.1016/j.wneu.2023.08.018. Epub 2023 Aug 12.
4
[Methotrexate-related lymphoproliferative disease showing different histological findings at recurrence].[甲氨蝶呤相关的淋巴增殖性疾病复发时呈现不同组织学表现]
Rinsho Ketsueki. 2023;64(2):97-101. doi: 10.11406/rinketsu.64.97.
5
Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder.基于磁共振波谱和寡克隆带预测中枢神经系统甲氨蝶呤相关性淋巴增殖性疾病的预后。
Intern Med. 2022 Dec 15;61(24):3733-3738. doi: 10.2169/internalmedicine.9296-21. Epub 2022 May 21.
6
Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.甲氨蝶呤诱导的淋巴增殖性疾病的临床病理研究,重点关注消退情况。
Leuk Lymphoma. 2018 May;59(5):1143-1152. doi: 10.1080/10428194.2017.1369073. Epub 2017 Sep 7.
7
Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.原发性中枢神经系统淋巴瘤的复发模式:关于神经血管单元和单克隆抗体在治疗隐匿性中枢神经系统疾病中的作用的推断。
Fluids Barriers CNS. 2017 Jun 2;14(1):16. doi: 10.1186/s12987-017-0064-3.
8
Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.甲氨蝶呤相关淋巴增殖性疾病的临床病理分析:弥漫性大B细胞淋巴瘤与经典型霍奇金淋巴瘤类型的比较
Cancer Sci. 2017 Jun;108(6):1271-1280. doi: 10.1111/cas.13249. Epub 2017 May 23.
9
Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.甲氨蝶呤相关B细胞淋巴增殖性疾病的类风湿关节炎患者中的爱泼斯坦-巴尔病毒感染与基因启动子高甲基化
Virchows Arch. 2017 Feb;470(2):205-215. doi: 10.1007/s00428-016-2030-x. Epub 2016 Nov 18.
10
Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.结外淋巴瘤的现代放射治疗:国际淋巴瘤放射肿瘤学组的照射野及剂量指南
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):11-31. doi: 10.1016/j.ijrobp.2015.01.009.